Neurotrope

NTRP NASDAQ
5.40
-0.09
-1.64%
交易中 11:52 07/23 EDT
开盘
5.39
昨收
5.49
最高
5.77
最低
5.39
成交量
3.75万
成交均量(3M)
6.68万
52周最高
10.50
52周最低
3.330
换手率
0.29%
市值
6,991.58万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Neurotrope NTRP股票价格,Neurotrope股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Neurotrope, Inc., formerly BlueFlash Communications, Inc., is a biopharmaceutical company with its product candidates in pre-clinical and clinical development. The Company is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. Bryostatin, which is a protein kinase C (PKC) Alpha and e activator, is also developed for other neurodegenerative or cognitive diseases and dysfunctions, which are in pre-clinical testing. Its second generation PKC activators, such as the Bryologs are meant for the treatment of central nervous system disorders, lysosomal storage diseases, stroke, cardio protection and traumatic brain injury. It develops Bryostatin-1 for the treatment of Alzheimer's disease along with the rare (Orphan) diseases, such as Fragile X Syndrome and Niemann-Pick Type C. It has completed Phase IIa clinical trials of Bryostatin-1 for the treatment of patients with AD.
展开 >

最近浏览

名称
价格
涨跌幅